Received Jul 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z007214 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
the patient did not experience any adverse side effects from administered dose; no adverse event; TE for PROQUAD with a prior excursion on 6/18/2025 and a current excursion on 07/02/2025 that was administered post excursion to a patient on 06/30/2025; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 30-Jun-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Injection (valid lot #Z007214, expiration date: 05-Oct-2026) 0.5 mL administered for prophylaxis (dose number, anatomical location and route of administration were not provided). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) Solution for injection (expiration date, and lot # were not reported). Administered dose of suspect vaccine was exposed to the temperature excursion on 18-JUN-2025: 6.8 Fahrenheit (F) for 0 hours, 47 minutes, 0 seconds (product storage error, onset date: 30-JUN-2025). The patient did not experience any adverse side effects from administered dose; no adverse event (no adverse event). This is one of several reports received from the same reporter.; Reporter's Comments: Keywords :